Monday, September 15, 2025
Second Sight Medical Products (EYES) exploded from a low of $1.40 to $20 this week before retreating to around $11.00. All on news the U.S. FDA approved its Argus 2s Retinal Prosthesis System. According to EYES, the System is, “a redesigned set of external hardware (glasses and video processing unit) initially for use in combination […]
Shares of Rocket Companies (RKT) recently zoomed to a high of $43 without any apparent new news from the company. However, the stock currently has large short bets placed against it by hedge funds and appears to have garnered some bullish interest from day traders on Reddit’s infamous r/WallStreetBets forum. Roughly 45% of RKT’s available […]
There’s a good deal of excitement with mobile gaming stocks, like Zynga (ZNGA). Since late November 2020, ZNGA ran from a low of about $8 to a high of $12.25. It has since pulled back to $10.23, but appears attractive with big catalysts ahead of it. One, spending on mobile gaming could grow to $120 […]
One of the most popular ETFs in 2021 is Cathie Wood’s Ark Innovation ETF (ARKK). ARKK invests in several of the most popular tech-related stocks like Tesla (TSLA) and Square (SQ). The ETF had done quite well until a recent bout of selling. On a big market down day last week, ARKK traded 7x the […]
REIT stocks give high yields and exposure to real estate without having to own property. We’ll explain what REITs are and what to look for.
Shortly after publishing our article, “What Happens When All Our Wealth Is Gone?” I received a heartfelt letter from subscriber Bill C. He speaks for many concerned, hard-working people: “First, I want to THANK YOU for writing a top notch and informative newsletter. It is one of the few emails that I get that I read immediately […]
By far the most frequent question we’ve had the last few weeks is it it time to buy bonds again. We’ll assess the risks associated with the market currently and how we can better position ourselves.
Ocugen Inc. (OCGN) has been explosive this year. Since late December 2020, OCGN ran from a low of just 29 cents to a recent high of $13. Helping, OCGN just announced that its co-development partner, Bharat Biotech, announced the results of the first interim analysis of its Phase 3 study of COVAXIN, which demonstrated a […]
This time last year, the WHO was about to label the novel coronavirus that was spreading across the globe a pandemic, and no one knew where it would lead, either for our health or the health of the economy. We were at the beginning of not only a deadly pandemic, but also a severe stock […]
Hydrogen pure-play stocks outperformed the overall market in 2020 and continue to do well in 2021. Hydrogen-related investments have attracted investor interest, as bullish sentiment believe the element — which emits no greenhouse gas when burned or used in fuel cells — may be a viable option to help the world meet its climate goals. […]
